Australia markets close in 3 hours 2 minutes

Maravai LifeSciences Holdings, Inc. (MRVI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.80+0.38 (+4.51%)
At close: 04:00PM EDT
8.42 -0.38 (-4.32%)
After hours: 07:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.17B
Enterprise value 1.20B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.02
Price/book (mrq)2.80
Enterprise value/revenue 4.16
Enterprise value/EBITDA 1.69

Trading information

Stock price history

Beta (5Y monthly) 0.01
52-week change 3-41.81%
S&P500 52-week change 321.33%
52-week high 316.62
52-week low 34.52
50-day moving average 37.89
200-day moving average 37.87

Share statistics

Avg vol (3-month) 32.77M
Avg vol (10-day) 31.63M
Shares outstanding 5132.66M
Implied shares outstanding 6123.67M
Float 898.53M
% held by insiders 12.35%
% held by institutions 1102.36%
Shares short (15 Apr 2024) 46.34M
Short ratio (15 Apr 2024) 42.3
Short % of float (15 Apr 2024) 45.75%
Short % of shares outstanding (15 Apr 2024) 44.79%
Shares short (prior month 15 Mar 2024) 47.35M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -41.19%
Operating margin (ttm)-9.09%

Management effectiveness

Return on assets (ttm)-0.81%
Return on equity (ttm)-16.33%

Income statement

Revenue (ttm)288.94M
Revenue per share (ttm)2.19
Quarterly revenue growth (yoy)-63.80%
Gross profit (ttm)N/A
EBITDA 15.89M
Net income avi to common (ttm)-119.03M
Diluted EPS (ttm)-0.90
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)574.96M
Total cash per share (mrq)4.35
Total debt (mrq)610.97M
Total debt/equity (mrq)77.35%
Current ratio (mrq)8.00
Book value per share (mrq)3.15

Cash flow statement

Operating cash flow (ttm)126.22M
Levered free cash flow (ttm)43.83M